Old Web
English
Sign In
Acemap
>
authorDetail
>
Guillermo Mendez
Guillermo Mendez
Fundación Favaloro
Medicine
Internal medicine
Cancer
Adjuvant
Gastroesophageal Junction
3
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Checkmate 577:Health-related quality of life (HRQoL) in a randomized, double-blind phase III study of nivolumab (NIVO) versus placebo (PBO) as adjuvant treatment in patients (pts) with resected esophageal or gastroesophageal junction cancer (EC/GEJC).
2021
Journal of Clinical Oncology
Eric Van Cutsem
Prianka Singh
James M. Cleary
Ronan J. Kelly
Markus Moehler
Jarosław Kużdżał
Guillermo Mendez
Satoru Motoyama
Elena Elimova
Cecile Grootscholten
Xiaowu Sun
Fiona Taylor
Rachael Lawrance
Brad Padilla
Alejandro Moreno-Koehler
Jenny Zhang
Steven I Blum
Jaffer A. Ajani
Show All
Source
Cite
Save
Citations (0)
Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): Expanded efficacy and safety analyses from CheckMate 577.
2021
Journal of Clinical Oncology
Ronan J. Kelly
Jaffer A. Ajani
Jarosław Kużdżał
Thomas Zander
Eric Van Cutsem
Guillaume Piessen
Guillermo Mendez
Josephine Feliciano
Satoru Motoyama
Astrid Lièvre
Hope E. Uronis
Elena Elimova
Cecile Grootscholten
Karen Geboes
Jenny Zhang
Samira Soleymani
Ming Lei
Prianka Singh
James M. Cleary
Markus Moehler
Show All
Source
Cite
Save
Citations (5)
Diagnosis recommendations and neuroendocrine tumors treatment of gastroenteropancreatic origin
2020
J O Connor
S Belli
Enzo Domenichini
A. Falco
F. Losada Lopez
Lisandro Paganini
S. Racioppi
G Acosta Haab
I. Armas
J. Lastiri
G. Bruno
S. Traverso
Ana Cabanne
M Rizzolo
Guillermo Mendez
K. Danilowicz
M. Dioca
Pablo Sánchez
Julia Ismael
S. Lupi
P. Méndez
Diego Ramisch
R. Rampa
J. Tkatch
Show All
Source
Cite
Save
Citations (0)
1